title: Reply: Effect of Pre-Procedural β-Blocker in Patients Undergoing Percutaneous Coronary Intervention.
authors.forename: Apurva A
authors.initials: AA
authors.lastname: Motivala
authors.forename: Valay
authors.initials: V
authors.lastname: Parikh
authors.forename: Matthew
authors.initials: M
authors.lastname: Roe
authors.forename: David
authors.initials: D
authors.lastname: Dai
authors.forename: J Dawn
authors.initials: JD
authors.lastname: Abbott
authors.forename: Abhiram
authors.initials: A
authors.lastname: Prasad
authors.forename: Debabrata
authors.initials: D
authors.lastname: Mukherjee
mesh_terms: D000319:Adrenergic beta-Antagonists; D006801:Humans; D009203:Myocardial Infarction; D062645:Percutaneous Coronary Intervention; D016896:Treatment Outcome
chemical_list: D000319:Adrenergic beta-Antagonists